Bruker Corporation to Present at Upcoming Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences:
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming investment bank conferences. The TD Cowen 45th Annual Healthcare Conference is being held in Boston,
Docebo Announces Participation in Upcoming Investor Conferences in March
Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), a global leader in AI-powered learning solutions, announced today that members of its management team will present at the following investor and software industry conferences in March 2025: For more information about these and other events,
Context Therapeutics to Showcase at Top 2025 Investor Conferences
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced its participation in several upcoming investor conferences. The Company will take part in the B. Riley Securities Precision Oncology & Radiopharma
Context Therapeutics to Participate in Upcoming Investor Conferences
Context will also participate in one-on-one meetings at each of the above conferences. About Context Therapeutics® Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors.
CrowdStrike to Participate in Upcoming Investor Conference
CrowdStrike (Nasdaq: CRWD), a global cybersecurity leader, has redefined modern security with the world's most advanced cloud-native platform for protecting critial areas of enterprise risk - endpoints and cloud workloads,
Hosted on MSN6d
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...
Bruker Co. (NASDAQ:BRKR) Receives $70.50 Consensus Target Price from Analysts
Shares of Bruker Co. (NASDAQ:BRKR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven ...
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before ...
Bruker projects 11%-13% EPS growth and 140 bps margin expansion for 2025 amid strong semi and diagnostics performance
Q4 2024 Management View Frank Laukien, President and CEO, reported that Bruker achieved Q4 2024 constant exchange rate (CER) revenue growth of 15.8%, with reported revenues reaching $979.6 million and ...
Stifel Nicolaus Cuts Bruker (NASDAQ:BRKR) Price Target to $57.00
Bruker (NASDAQ:BRKR – Free Report) had its target price reduced by Stifel Nicolaus from $70.00 to $57.00 in a report issued on Friday morning,Benzinga reports. Stifel Nicolaus currently has a hold ...
Seeking Alpha7d
Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript
Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the ...
The Hour7d
Bruker: Q4 Earnings Snapshot
BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...